Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Yasunari Nagasaki"'
Autor:
Hiromichi Yamane, Nobuaki Ochi, Ayaka Mimura, Yoko Kosaka, Naruhiko Ichiyama, Tatsuyuki Kawahara, Yasunari Nagasaki, Hidekazu Nakanishi, Nagio Takigawa
Publikováno v:
Palliative Medicine Reports, Vol 4, Iss 1, Pp 278-287 (2023)
Background: In Japan, the number of patients with aggressive hematological malignancies (PHMs) admitted at the palliative care unit (PCU) in their end-of-life (EOL) stage was fewer than that of patients with solid tumors due to several reasons. The a
Externí odkaz:
https://doaj.org/article/bd058afdb6394ef2913727a56a17652c
Autor:
Yuta Ishida, Takuro Yukawa, Yasunari Nagasaki, Daisuke Minami, Hiroyasu Fujiwara, Yasumasa Monobe, Takuya Fukazawa, Tomoki Yamatsuji
Publikováno v:
Thoracic Cancer, Vol 14, Iss 21, Pp 2085-2089 (2023)
Abstract A 52‐year‐old female never‐smoker with an abnormal shadow in the right lung detected on radiography was referred to our institution. Contrast‐enhanced computed tomography revealed an irregular nodule in the upper lobe of the right lu
Externí odkaz:
https://doaj.org/article/469f85cc0af946618d390b4be10d1135
Autor:
Hiromichi Yamane, Yasunari Nagasaki, Tatsuyuki Kawahara, Naruhiko Ichiyama, Yoko Kosaka, Nobuaki Ochi, Hidekazu Nakanishi, Nagio Takigawa
Publikováno v:
Thoracic Cancer, Vol 14, Iss 16, Pp 1538-1539 (2023)
Externí odkaz:
https://doaj.org/article/fa2bee93263441289abe0e5adc6e4652
Autor:
Naruhiko Ichiyama, Hiromichi Yamane, Nobuaki Ochi, Nozomu Nakagawa, Yasunari Nagasaki, Tatsuyuki Kawahara, Masataka Taoka, Ayaka Mimura, Hidekazu Nakanishi, Nagio Takigawa
Publikováno v:
Thoracic Cancer, Vol 12, Iss 9, Pp 1467-1468 (2021)
Externí odkaz:
https://doaj.org/article/3352e7f6eb2146099597a7398861d229
Autor:
Nozomu Nakagawa, MD, Nobuaki Ochi, MD, PhD, Hiromichi Yamane, MD, PhD, Yoshihiro Honda, MD, PhD, Yasunari Nagasaki, MD, Noriyo Urata, MD, Hidekazu Nakanishi, MD, PhD, Hirofumi Kawamoto, MD, PhD, Nagio Takigawa, MD, PhD
Publikováno v:
Radiology Case Reports, Vol 13, Iss 1, Pp 43-46 (2018)
A 74-year-old man was treated with ceftriaxone for 5 days and subsequently experienced epigastric pain. Computed tomography (CT) was performed 7 and 3 days before epigastralgia. Although the first CT image revealed no radiographic signs in his biliar
Externí odkaz:
https://doaj.org/article/af57a4c2d1574f27916918220823bc4f
Autor:
Hidekazu Nakanishi, Yasumasa Monobe, Yoshiyuki Oshiro, Nagio Takigawa, Masataka Taoka, Nobuaki Ochi, Nozomu Nakagawa, Naruhiko Ichiyama, Ayaka Mimura, Hiromichi Yamane, Yasunari Nagasaki
Publikováno v:
Therapeutics and Clinical Risk Management
A 72-year-old man with locally advanced lung squamous cell carcinoma experienced red purpura on the lower legs and hematuria when the disease progressed during definitive chemoradiotherapy. He had renal dysfunction and proteinuria. Biopsy specimens o
Autor:
Nobuaki Ochi, Masami Takeyama, Noriko Miyake, Maki Fuchigami, Hiromichi Yamane, Takuya Fukazawa, Yasunari Nagasaki, Tatsuyuki Kawahara, Hidekazu Nakanishi, Nagio Takigawa
Publikováno v:
Experimental Cell Research. 424:113503
Autor:
Hidekazu Nakanishi, Hiromichi Yamane, Masami Takeyama, Takuya Fukazawa, Nozomu Nakagawa, Hiroyuki Kohara, Noriko Miyake, Nobuaki Ochi, Yasunari Nagasaki, Naruhiko Ichiyama, Tomoki Yamatsuji, Nagio Takigawa, Tomoko Ikeda, Tatsuyuki Kawahara, Etsuko Yokota, Yoshio Naomoto
Publikováno v:
Lung Cancer. 139:170-178
Objective Receptor tyrosine kinase-like orphan receptor 1 (ROR1) is overexpressed in a subset of malignant cells. However, it remains unknown whether ROR1 is targetable in malignant mesothelioma (MM). Therefore, in this study, we investigated the eff
Autor:
Masataka Taoka, Nobuaki Ochi, Hiromichi Yamane, Takenobu Yamamoto, Tatsuyuki Kawahara, Emiko Uji, Youko Kosaka, Kouhei Takeda, Yasunari Nagasaki, Hidekazu Nakanishi, Yumi Aoyama, Nagio Takigawa
Publikováno v:
Translational cancer research. 11(3)
Herpes zoster (HZ) occurs mostly in elderly and immunocompromised individuals. Immune reconstitution may be associated with the pathogenesis of HZ. As immune checkpoint inhibitor (ICI) treatment amplifies the immune response, use of ICI may increase
Autor:
Katsuyuki Kiura, Takuya Fukazawa, Daijiro Harada, Masami Takeyama, Hiromichi Yamane, Tomoko Ikeda, Noriko Miyake, Nobuaki Ochi, Nagio Takigawa, Nozomu Nakagawa, Etsuko Yokota, Hidekazu Nakanishi, Yasunari Nagasaki
Publikováno v:
Experimental cell research. 409(2)
Lung cancer that exhibits epidermal growth factor receptor (EGFR) gene mutation is sensitive to EGFR-tyrosine kinase inhibitors (TKIs), such as osimertinib. Receptor tyrosine kinase-like orphan receptor 1 (ROR1) may be involved in overcoming EGFR-TKI